by B Langguth 2024 Cited by 122Treatment of tinnitus with cyclobenzaprine: an open-label study. Int. J Partial to complete suppression of unilateral noise-induced tinnitus in rats after
Our results indicate that cyclobenzaprine is a promising drug to treat tinnitus particularly in certain subgroups.
The studies on cyclobenzaprine reducing tinnitus are why I believe it can help with muscle-related hyperacusis. I believe some of these tinnitus cases may have tinnitus for the same reason, as my reactive tinnitus is definitely aligned with my hyperacusis.
Two open preliminary studies evaluated the action of cyclobenzaprine in the treatment of tinnitus have shown evidences that this drug presents a
In the present study, for the subset of animals with GPIAS deficits consistent with the presence of tinnitus, treatment with cyclobenzaprine significantly reduced evidence of tinnitus (i.e, GPIAS returned toward baseline levels).
In two recent open-label studies, cyclobenzaprine significantly reduced tinnitus distress and tinnitus handicap (Coelho et al. 2024; Vanneste et al. 2024 ).
Our results indicate that cyclobenzaprine is a promising drug to treat tinnitus particularly in certain subgroups. As there is a good risk-benefit ratio and there are currently no well-established, specific treatments for tinnitus, cyclobenzaprine might be worthwhile to further investigate.
Tinnitus. Definition: A nonspecific symptom of hearing disorder characterized cyclobenzaprine cyclophosphamide: postmarketing; cyproheptadine dapsone
Latest News and Articles on Tinnitus. Read stories and expert opinion articles on Tinnitus at thehealthsite cyclobenzaprine and baclofen, and surgery.
I am nearing the end of finishing Chapter 18, and I'm working hard. Still having days when I can't even read words on a page. After more than three years, there is finally a diagnosis, and the issue now is can they find the cause to determine if some of the side effects are reversible -- dizziness, tinnitus, shooting body pains, migraines, vision problems, and worse, sometimes cognitive issues.
My reader has read the first part, and it eagerly awaiting the rest of the story. Time to get back to writing. Slainté